A clinical trial almost 10 years in the making has revealed that risky, but powerful, clot busting drugs and medical devices do not improve outcomes for patients experiencing deep vein thrombosis (DVT), nor do they prevent ...
Dec 11, 2017
0
1
Not all patients with blood clots in their legs - a condition known as deep vein thrombosis - need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.
Dec 6, 2017
0
9
Researchers at Cardiff University have discovered a new family of lipids (fats) that plays a key role in controlling clot formation. The new discovery could lead to novel ways of reducing the risk of excess clotting, called ...
Nov 29, 2017
0
1
(HealthDay)—Seniors with a fractured hip need surgery as soon as possible or they could suffer life-threatening complications, a new Canadian study concludes.
Nov 28, 2017
0
4
Monash University researchers have potentially shed light on why women with the rare autoimmune disorder Antiphospholipid syndrome (APS) are prone to successive pregnancy losses.
Nov 28, 2017
0
711
General practitioners trained in compression ultrasonography have excellent accuracy and agreement in diagnosing symptomatic proximal deep vein thrombosis.
Nov 16, 2017
0
1
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural ...
Nov 8, 2017
0
0
(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA Internal Medicine.
Nov 7, 2017
0
0
Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular ...
Nov 2, 2017
0
0
(HealthDay)—Everolimus-eluting bioresorbable vascular scaffolds (BVSs) are associated with increased odds of scaffold thrombosis and other thrombotic events compared with everolimus-eluting metallic stents (EESs), according ...
Oct 17, 2017
0
0
